/주식/BIIB
BIIB

BIIB

USD

Biogen Inc. Common Stock

$154.872-0.828 (-0.532%)

실시간 가격

Healthcare
Drug Manufacturers - General
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$155.700

고가

$156.220

저가

$154.010

거래량

1.72M

기업 기본 정보

시가총액

22.7B

산업

Drug Manufacturers - General

국가

United States

거래 통계

평균 거래량

1.64M

거래소

NMS

통화

USD

52주 범위

저가 $110.04현재가 $154.872고가 $175.86

관련 뉴스

Analyst Upgrades

Bernstein Maintains Market Perform on Biogen, Raises Price Target to $157

Bernstein analyst William Pickering maintains Biogen with a Market Perform and raises the price target from $155 to $157.

더 보기
Bernstein Maintains Market Perform on Biogen, Raises Price Target to $157
GlobeNewswire

Biogen to Highlight Scientific Progress in Rare Kidney Disease at American Society of Nephrology (ASN) Kidney Week 2025

Oral presentation to share first-of-its-kind longitudinal gene expression data in IgA nephropathy, unveiling novel insights into the mechanism of action of felzartamab and advancing the understanding of its disease

더 보기
Biogen to Highlight Scientific Progress in Rare Kidney Disease at American Society of Nephrology (ASN) Kidney Week 2025
Analyst Upgrades

RBC Capital Maintains Outperform on Biogen, Lowers Price Target to $210

RBC Capital analyst Brian Abrahams maintains Biogen with a Outperform and lowers the price target from $217 to $210.

더 보기
RBC Capital Maintains Outperform on Biogen, Lowers Price Target to $210
Reuters

Biogen tops quarterly profit estimates, eyes deals to build early-stage pipeline

Biogen beat Wall Street estimates for third-quarter profit, helped by better-than-expected sales of some of its multiple sclerosis treatments.

더 보기
Biogen tops quarterly profit estimates, eyes deals to build early-stage pipeline